Synthesis, antimalarial activity and cytotoxic potential of new monocarbonyl analogues of curcumin.
Basic Information
ID: ALA2311414
Journal: Bioorg Med Chem Lett
Title: Synthesis, antimalarial activity and cytotoxic potential of new monocarbonyl analogues of curcumin.
Authors: Manohar S, Khan SI, Kandi SK, Raj K, Sun G, Yang X, Calderon Molina AD, Ni N, Wang B, Rawat DS.
Abstract: A series of novel monocarbonyl analogues of curcumin have been designed, synthesized and tested for their activity against Molt4, HeLa, PC3, DU145 and KB cancer cell lines. Six of the analogues showed potent cytotoxicity towards these cell lines with IC(50) values below 1 μM, which is better than doxorubicin, a US FDA approved drug. Several analogues were also found to be active against both CQ-resistant (W2 clone) and CQ-sensitive (D6) strains of Plasmodium falciparum in an in-vitro antimalarial screening. This level of activity warrants further investigation of the compounds for development as anticancer and antimalarial agents.
CiteXplore: 23218718
DOI: 10.1016/j.bmcl.2012.11.004
Patent ID: ┄